Categories
Recent Articles
-
The Science Behind Retatrutide: A New Hope for Obesity and Diabetes
92 days ago
Retatrutide is an innovative triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, offering a...
-
The Science Behind Tirzepatide: GLP-1 and GIP Dual Action
92 days ago
Tirzepatide, a dual GIP/GLP-1 receptor agonist, helps regulate blood sugar and appetite, supporting weight loss,...
All product descriptions and articles provided on this website are intended strictly for informational and educational purposes. Our products are designed exclusively for in-vitro research (i.e., experiments conducted outside of a living organism, typically in glassware such as test tubes or petri dishes). These compounds are not approved by the FDA for use in humans or animals. They are not medications, nor are they intended to diagnose, treat, prevent, or cure any disease or medical condition. Any bodily administration-human or animal-is strictly prohibited by law. Our products are not for human consumption under any circumstances.
The Science Behind Retatrutide: A New Hope for Obesity and Diabetes
Retatrutide is an innovative triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, offering a promising approach for obesity and type 2 diabetes. Clinical trials show up to 24% weight loss and significant HbA1c reduction, surpassing many current treatments. By addressing multiple metabolic pathways simultaneously, Retatrutide improves appetite control, fat metabolism, and energy expenditure. Ongoing research continues to explore its full potential in metabolic health.
The Science Behind Tirzepatide: GLP-1 and GIP Dual Action
Tirzepatide, a dual GIP/GLP-1 receptor agonist, helps regulate blood sugar and appetite, supporting weight loss, improved insulin sensitivity, and metabolic health. Prime Lab Peptides offers a high-quality, effective solution for sustainable diabetes and weight management.